


Healthcare News Roundup: Biopharmaceuticals
HSMN NewsFeed - 15 Dec 2025
Sobi to Acquire Arthrosi Therapeutics, Strengthening Pipeline for the Potential Treatment of Gout
Sobi to Acquire Arthrosi Therapeutics, Strengthening Pipeline for the Potential Treatment of Gout
HSMN NewsFeed - 12 Dec 2025
Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline
Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline
HSMN NewsFeed - 10 Dec 2025
Expression Therapeutics Appoints Industry Veteran Dr. David Townson as Chief Executive Officer
Expression Therapeutics Appoints Industry Veteran Dr. David Townson as Chief Executive Officer
HSMN NewsFeed - 28 Nov 2025
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
HSMN NewsFeed - 5 Nov 2025
Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
HSMN NewsFeed - 4 Nov 2025
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer
